Facing $4B in claims, Insys doubts ability to pay out via Chapter 11

Facing more than $4 billion in claims from 8,000-plus filings, Insys Therapeutics does not expect to come close to fulfilling all outstanding demands, but has proposed a path forward in bankruptcy court anyway.